← Open Payments lookup

AMANDA HALL: Open Payments

NPI 1124699178 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$470 in 27 payments from 11 companies in 2025. Trend: 2023 $622 · 2024 $370 · 2025 $470

Food & beverage: $470
CompanyPaymentsAmount
ABBVIE INC.8$162
GENZYME CORPORATION2$50
Ipsen Biopharmaceuticals, Inc2$43
Phathom Pharmaceuticals, Inc.5$41
Janssen Biotech, Inc.2$33
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$32
Ardelyx, Inc.2$32
Lilly USA, LLC1$22
Madrigal Pharmaceuticals1$21
Takeda Pharmaceuticals U.S.A., Inc.1$17

Products named: LINZESS, CREON, DUPIXENT, IQIRVO, VOQUEZNA, TREMFYA, XIFAXAN, IBSRELA.

Industry payments across NE — which companies pay providers there.